Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis

Steven J Edwards, Charlotta Karner, Tracey Jhita, Samantha Barton, Gemma Marceniuk, Zenas Z N Yiu, Miriam Wittmann

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science